000			01850 a2200529 4500
005			20250515223231.0
264		0	_c20100614
008			201006s 0 0 eng d
022			_a1460-2105
024	7		_a10.1093/jnci/djq125 _2doi
040			_aNLM _beng _cNLM
100	1		_aLi, Zhijie
245	0	0	_aIn vitro and in vivo inhibition of neuroblastoma tumor cell growth by AKT inhibitor perifosine. _h[electronic resource]
260			_bJournal of the National Cancer Institute _cJun 2010
300			_a758-70 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Intramural
650	0	4	_aAnalysis of Variance
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Agents _xpharmacology
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aCaspase 3 _xmetabolism
650	0	4	_aCaspase 7 _xmetabolism
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Survival _xdrug effects
650	0	4	_aClinical Trials as Topic
650	0	4	_aDisease Models, Animal
650	0	4	_aGrowth Inhibitors _xpharmacology
650	0	4	_aHumans
650	0	4	_aIn Vitro Techniques
650	0	4	_aKaplan-Meier Estimate
650	0	4	_aLuciferases
650	0	4	_aLuminescent Agents
650	0	4	_aMice
650	0	4	_aMutation
650	0	4	_aNIH 3T3 Cells
650	0	4	_aNeuroblastoma _xdrug therapy
650	0	4	_aPhosphorylation _xdrug effects
650	0	4	_aPhosphorylcholine _xanalogs & derivatives
650	0	4	_aProto-Oncogene Proteins c-akt _xantagonists & inhibitors
650	0	4	_aTransplantation, Heterologous
700	1		_aTan, Fei
700	1		_aLiewehr, David J
700	1		_aSteinberg, Seth M
700	1		_aThiele, Carol J
773	0		_tJournal of the National Cancer Institute _gvol. 102 _gno. 11 _gp. 758-70
856	4	0	_uhttps://doi.org/10.1093/jnci/djq125 _zAvailable from publisher's website
999			_c19818043 _d19818043